Silica nanomatrix enhances immunotherapy for solid tumors
Cancer has long remained a leading cause of death worldwide and in Hong Kong, accounting for 30% of…
Inflammation and immune suppression fuel aggressive SCLC behavior and spread
Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer, with a five-year…
Tumor discovery may help advance precision chemo
Share this Article You are free to share this article under the Attribution 4.0 International license. A link…
Given the all clear from cancer, 6yo Laylah celebrates by ringing the bell at the Queensland Children’s Hospital
It’s the only bell more wonderful than jingle bells. When six-year-old Laylah-Jane Morton rang the bell at the…
Targeted mRNA vaccines train the immune system to destroy cancer cells
No matter where cancer cells grow in the human body, they are a threat to our health and…
Bifunctional biomaterials for postoperative management of osteosarcoma
Background Osteosarcoma is the most prevalent primary malignant bone tumor in children and adolescents. The current standard treatment…
Using sound waves to soften tumors and boost chemotherapy
Cancer is one of the leading causes of death in the U.S., second only to heart disease. But…
Dinutuximab beta plus chemotherapy shrinks neuroblastoma tumors in children
Children with a rare form of cancer called neuroblastoma which hasn’t responded to initial treatment or that has…
Tianjin grading system improves prognosis prediction in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is notoriously difficult to treat due to its aggressive nature and limited prognostic tools.…
Nanoflower-treated stem cells deliver healthier mitochondria to stressed cells
By engineering nanomaterials that boost mitochondrial biogenesis, researchers show how stem cells can become powerful “mitochondrial biofactories,” offering…
Chemotherapy-free combination treatment outperforms traditional regimens in patients with Ph+ ALL
A chemotherapy-free combination treatment outperformed a combination of targeted therapy and chemotherapy among patients with Ph+ acute lymphoblastic…
Aza-ven shows superior outcomes compared to induction chemotherapy in AML patients
In a new trial, patients newly diagnosed with acute myeloid leukemia (AML) fared significantly better with a combined…